2005Chinese Journal of NeuromedicineRequires access

Complications of 469 brain arteriovenous malformations treated with N-butyl cyanoacrylate

Yin Fang-min

Open publisher page 0 citations

Abstract

Objective To probe into incidence and risk factors of complications of brain arteriovenous malformation (AVM) following N-butyl cyanoacrylate (NBCA) embolization. Methods All clinical data and image findings of 469 brain AVM patients who underwent embolization with NBCA were studied retrospectively. The complications and their relation to their angiographic features were summed up. Results The 469 patients accepted totally 1108 endovascular embolization, each with 1~8 times (average 2.3 times). 11 patients developed treatment-related complications, including 4 hemorrhagic and 7 ischemic complications. Of these 11 cases, 2 died, 1 had vegetative state, 1 mild permanent functional deficit and other 7 temporary neurological deficits. Conclusion The patients of brain AVM treated with NBCA embolization have fewer treatment-related complications, but the ones who have high risk of embolization should be treated with special embolization strategies.

About this research paper

What this paper is about

Objective To probe into incidence and risk factors of complications of brain arteriovenous malformation (AVM) following N-butyl cyanoacrylate (NBCA) embolization. Methods All clinical data and image findings of 469 brain AVM patients who underwent embolization with NBCA were studied retrospectively. The complications and their relation to their angiographic features were summed up. Results The 469 patients accepted totally 1108 endovascular embolization, each with 1~8 times (average 2.3 times). 11 patients developed treatment-related complications, including 4 hemorrhagic and 7 ischemic complications. Of these 11 cases, 2 died, 1 had vegetative state, 1 mild permanent functional deficit and other 7 temporary neurological deficits. Conclusion The patients of brain AVM treated with NBCA embolization have fewer treatment-related complications, but the ones who have high risk of embolization should be treated with special embolization strategies.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To probe into incidence and risk factors of complications of brain arteriovenous malformation (AVM) following N-butyl cyanoacrylate (NBCA) embolization. Methods All clinical data and image findings of 469 brain AVM patients who underwent embolization with NBCA were studied retrospectively. The complications and their relation to their angiographic features were summed up. Results The 469 patients accepted totally 1108 endovascular embolization, each with 1~8 times (average 2.3 times). 11 patients developed treatment-related complications, including 4 hemorrhagic and 7 ischemic complications. Of these 11 cases, 2 died, 1 had vegetative state, 1 mild permanent functional deficit and other 7 temporary neurological deficits. Conclusion The patients of brain AVM treated with NBCA embolization have fewer treatment-related complications, but the ones who have high risk of embolization should be treated with special embolization strategies.

Key concepts: Embolization, Cyanoacrylate, Medicine, Arteriovenous malformation, Surgery, Incidence (geometry), Neurological deficit, Intracranial Arteriovenous Malformations

Related papers

Back to paper searchBrowse research topicsOriginal source
Complications of 469 brain arteriovenous malformations treated with N-butyl cyanoacrylate — Research Paper | ScholarLens